MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Gait disorders: Genetics"

  • 2025 International Congress

    Genetics of African Americans – Louisiana, Parkinson’s Disease – (GoAAL-PD)

    J. Staisch, S. Breaux, D. Thomas, C. Cevallos, C. Robinson, J. Hines, A. Bonano, L. Davis, J. Henry, N. Crovetto, E. Levenes (New Orleans, USA)

    Objective: Study a cohort of African American patients with PD to understand the genetic underpinnings, phenotypes, barriers to care, and engagement preferences unique to this…
  • 2024 International Congress

    Progressive Cerebellar Ataxia as the Predominant Symptomatology of SGP-7 Compound Heterozygote Pathogenic Variants related HSP-7

    D. Menghani, T. Yamasaki (Nicholasville, USA)

    Objective: Analyze a clinical case detailing the presentation of a patient primarily exhibiting gradual onset balance disturbances, subsequently diagnosed with HSP-7, elucidating key diagnostic challenges…
  • 2024 International Congress

    A novel G413S mutation in the CSF1R gene causes Hereditary Diffuse Leucoencephalopathy with axonal Spheroids; clinically overlapping features of Parkinsonism

    ANW. Ullah, MZB. Badshah (Peshawar, Nepal)

    Objective: The current study was designed to investigate the genetic cause of atypical Parkinsonism is a multigenerational Pakistani family Background: Hereditary Diffuse Leucoencephalopathy with axonal…
  • 2024 International Congress

    New Pathological Findings in an International Cohort of Hereditary Spastic Paraplegia 4 Patients

    A. Orlacchio, A. Meyyazhagan, P. Eusebi, P. Basavaraju, H. Kuchi Bhotla, M. Stasi, G. Ribas, I. Faber, R. Miyamoto, M. Miele, R. Massa, P. Patti, M. França Jr, J. Pedroso, O. Barsottini, H. Teive, T. Kawarai, E. Panza (Perugia, Italy)

    Objective: To determine the clinical and genetic differences in hereditary spastic paraplegia SPG4 patients across various countries. Background: SPG4/SPAST gene account for approximately 40% of…
  • 2024 International Congress

    Validation of Inertial Measurement Units and an application compared with the reference system to assess the gait in hereditary spastic paraplegia

    D. Cubillos-Arcila, A. Ivaniski-Mello, E. de Borba, L. Peyré-Tartaruga, J. Morales Saute (Porto Alegre, Brazil)

    Objective: To assess the reliability of spatiotemporal parameter measurements in HSP patients obtained from an inertial system and an application compared with the conventional motion…
  • 2024 International Congress

    Autosomal Recessive Spastic Ataxia Secondary a Novel SPG7 Gene Pathogenic Variant: a Case Report

    K. Salinas-Barboza, J. Altamirano, A. Armas-Salazar (CDMX, Mexico)

    Objective: The primary aim of this investigation is to describe a newly identified pathogenic variant within the SPG7 gene observed in a clinical presentation of…
  • 2024 International Congress

    Dopa-responsive ataxia with compound heterozygous variants in MRE11

    A. Dugar, E. Levine, M. Barbosa, W. Tse (New York, USA)

    Objective: To evaluate the role for levodopa in patients with ataxia telangiectasia like disorder (ATLD) who have a compound heterozygous mutation in MRE11. Background: Early-onset…
  • 2024 International Congress

    PMM2 mutation

    H. Teive, J. Duarte, LE. de Farias, S. Raskin, F. Tensini, D. Amarante (Curitiba, Brazil)

    Objective: describe glycosylation type 1A PMM2 mutation presented as motor development regression and cognitive impairment proving to be a disease that should’ve been detected precociously.…
  • 2024 International Congress

    Perry Syndrome due to a DCTN1 novel variant

    P. Lorenzo-Barreto, I. Muro-García, E. Casas-Peña, JP. Romero-Muñoz, L. López-Manzanares (Madrid, Spain)

    Objective: To report the clinical features of a patient with Perry syndrome (PS) due to a heterozygous novel pathogenic variant in the DCTN1 gene. Background:…
  • 2024 International Congress

    Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program

    D. Vaughan, M. Theilmann Jensen, O. Serrano Asensio, T. Tharmaraja, S. Jasaityte, E. Stafford, H. Houlden, A. Huey Tan, S. Lim, H. Morris, GP2. Genetics Program (London, United Kingdom)

    Objective: To integrate Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program (GP2) and design a dictionary of data to be collected. Background: GP2 is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley